Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.
2.

Quantitative proteomics and biochemical analyses reveal the role of endoplasmin in the regulation of the expression and secretion of A Disintegrin And Metalloproteinase 12.

Xiong L, Yan W, Zubia E, Zhou Y, Zhang Y, Duan Q, Narayan M, Xu G.

J Proteomics. 2018 Jun 30;182:34-44. doi: 10.1016/j.jprot.2018.04.033. Epub 2018 May 2.

PMID:
29729432
3.

An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.

Luo ML, Zhou Z, Sun L, Yu L, Sun L, Liu J, Yang Z, Ran Y, Yao Y, Hu H.

Cancer Lett. 2018 May 28;422:118-128. doi: 10.1016/j.canlet.2018.02.031. Epub 2018 Feb 21.

PMID:
29476791
4.

Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.

Xu Y, Wang Y, Liu H, Kang X, Li W, Wei Q.

Oncotarget. 2016 Sep 20;7(38):61716-61727. doi: 10.18632/oncotarget.11436.

5.

Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.

Kauttu T, Mustonen H, Vainionpää S, Krogerus L, Ilonen I, Räsänen J, Salo J, Puolakkainen P.

Clin Transl Oncol. 2017 Jan;19(1):58-66. doi: 10.1007/s12094-016-1503-3. Epub 2016 Mar 30.

PMID:
27026568
6.

Expression of ADAM12 is regulated by E2F1 in small cell lung cancer.

Li Z, Wang Y, Kong L, Yue Z, Ma Y, Chen X.

Oncol Rep. 2015 Dec;34(6):3231-7.

PMID:
26503019
7.

ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.

Shao S, Li Z, Gao W, Yu G, Liu D, Pan F.

PLoS One. 2014 Jan 21;9(1):e85936. doi: 10.1371/journal.pone.0085936. eCollection 2014.

8.

Ephrin-A1 expression induced by S100A8 is mediated by the toll-like receptor 4.

Ieguchi K, Omori T, Komatsu A, Tomita T, Deguchi A, Maru Y.

Biochem Biophys Res Commun. 2013 Nov 1;440(4):623-9. doi: 10.1016/j.bbrc.2013.09.119. Epub 2013 Oct 5.

PMID:
24103748
9.

ADAM12-cleaved ephrin-A1 contributes to lung metastasis.

Ieguchi K, Tomita T, Omori T, Komatsu A, Deguchi A, Masuda J, Duffy SL, Coulthard MG, Boyd A, Maru Y.

Oncogene. 2014 Apr 24;33(17):2179-90. doi: 10.1038/onc.2013.180. Epub 2013 May 20.

PMID:
23686306
10.

Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition.

Kogure M, Takawa M, Cho HS, Toyokawa G, Hayashi K, Tsunoda T, Kobayashi T, Daigo Y, Sugiyama M, Atomi Y, Nakamura Y, Hamamoto R.

Cancer Lett. 2013 Aug 9;336(1):76-84. doi: 10.1016/j.canlet.2013.04.009. Epub 2013 Apr 18.

PMID:
23603248
11.

ADAM 12: a putative marker of oligodendrogliomas?

Kanakis D, Lendeckel U, Theodosiou P, Dobrowolny H, Mawrin C, Keilhoff G, Bukowska A, Dietzmann K, Bogerts B, Bernstein HG.

Dis Markers. 2013;34(2):81-91. doi: 10.3233/DMA-120953.

12.

Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth.

Do EK, Kim YM, Heo SC, Kwon YW, Shin SH, Suh DS, Kim KH, Yoon MS, Kim JH.

Int J Biochem Cell Biol. 2012 Nov;44(11):2069-76. doi: 10.1016/j.biocel.2012.08.004. Epub 2012 Aug 10.

PMID:
22903068
13.

The newcomer in the integrin family: integrin α9 in biology and cancer.

Høye AM, Couchman JR, Wewer UM, Fukami K, Yoneda A.

Adv Biol Regul. 2012 May;52(2):326-39. doi: 10.1016/j.jbior.2012.03.004. Epub 2012 Mar 30. Review.

PMID:
22781746
14.

Serum levels of ADAM12-S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis.

Taniguchi T, Asano Y, Akamata K, Aozasa N, Noda S, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Kadono T, Sato S.

J Eur Acad Dermatol Venereol. 2013 Jun;27(6):747-53. doi: 10.1111/j.1468-3083.2012.04558.x. Epub 2012 Apr 28.

PMID:
22540429
15.

ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.

Fröhlich C, Nehammer C, Albrechtsen R, Kronqvist P, Kveiborg M, Sehara-Fujisawa A, Mercurio AM, Wewer UM.

Mol Cancer Res. 2011 Nov;9(11):1449-61. doi: 10.1158/1541-7786.MCR-11-0100. Epub 2011 Aug 29.

16.

Molecular characterization and expression analysis of ADAM12 during chicken embryonic development.

Lin J, Luo J, Redies C.

Dev Growth Differ. 2010 Dec;52(9):757-69. doi: 10.1111/j.1440-169X.2010.01212.x.

PMID:
21158755
17.

Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.

Ray A, Dhar S, Ray BK.

Mol Cancer Res. 2010 Sep;8(9):1261-70. doi: 10.1158/1541-7786.MCR-10-0212. Epub 2010 Aug 5.

18.

Potential markers of preeclampsia--a review.

Grill S, Rusterholz C, Zanetti-Dällenbach R, Tercanli S, Holzgreve W, Hahn S, Lapaire O.

Reprod Biol Endocrinol. 2009 Jul 14;7:70. doi: 10.1186/1477-7827-7-70. Review.

19.

A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.

Mino N, Miyahara R, Nakayama E, Takahashi T, Takahashi A, Iwakiri S, Sonobe M, Okubo K, Hirata T, Sehara A, Date H.

J Surg Oncol. 2009 Sep 1;100(3):267-72. doi: 10.1002/jso.21313.

PMID:
19544357
20.

Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervix.

Zubel A, Flechtenmacher C, Edler L, Alonso A.

Gynecol Oncol. 2009 Aug;114(2):332-6. doi: 10.1016/j.ygyno.2009.05.005. Epub 2009 May 27.

PMID:
19473694

Supplemental Content

Loading ...
Support Center